Original language | English (US) |
---|---|
Pages (from-to) | 330-332 |
Number of pages | 3 |
Journal | The Lancet Respiratory Medicine |
Volume | 9 |
Issue number | 4 |
DOIs |
|
State | Published - Apr 2021 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet Respiratory Medicine, Vol. 9, No. 4, 04.2021, p. 330-332.
Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - Geography, generalisability, and susceptibility in clinical trials
AU - Clougherty, Jane E.
AU - Kinnee, Ellen J.
AU - Cardet, Juan Carlos
AU - Mauger, David
AU - Bacharier, Leonard
AU - Beigelman, Avraham
AU - Blake, Kathryn V.
AU - Cabana, Michael D.
AU - Castro, Mario
AU - Chmiel, James F.
AU - Covar, Ronina
AU - Fitzpatrick, Anne
AU - Gaffin, Jonathan M.
AU - Gentile, Deborah
AU - Israel, Elliot
AU - Jackson, Daniel J.
AU - Kraft, Monica
AU - Krishnan, Jerry A.
AU - Kumar, Harsha Vardhan
AU - Lang, Jason E.
AU - Lazarus, Stephen C.
AU - Lemanske, Robert F.
AU - Lima, John
AU - Martinez, Fernando D.
AU - Morgan, Wayne
AU - Moy, James
AU - Myers, Ross
AU - Naureckas, Edward T.
AU - Ortega, Victor E.
AU - Peters, Stephen P.
AU - Phipatanakul, Wanda
AU - Pongracic, Jacqueline A.
AU - Ross, Kristie
AU - Sheehan, William J.
AU - Smith, Lewis J.
AU - Solway, Julian
AU - Sorkness, Christine A.
AU - Wechsler, Michael E.
AU - Wenzel, Sally
AU - White, Steven R.
AU - Holguin, Fernando
N1 - Funding Information: This work was funded by the NIH National Heart, Lung, and Blood Institute (NHLBI) (1R01HL114536–01: Validating GIS-based methods to address spatial uncertainty in clinical trials, to JEC and FH). The AsthmaNet trials were funded by NIH grants HL098302, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, 098103, and HL098115. All competing interests listed here are during the conduct of the study; competing interests outside of the submitted work are listed in the appendix . JEC, EJK, RC, SPP, LB, KVB, DJJ, FDM, WM, JAP, JS, and SRW report grants from the NIH NHLBI. DM and JFC report grants from the NIH. AB reports grants from Washington University and the NIH. MDC is a member of the United States Preventive Services Task Force (USPSTF); this manuscript does not necessarily represent the views of the USPSTF. JAK reports grants from the NIH, NHBLI, and PCORI. WP reports grants, personal fees, and other support from Genentech/Novartis and Regeneron/Sanofi, other support from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, and Merck. Additionally, full details for competing interests outside of the submitted work for DM, LB, JFC, DJJ, FDM, WM, JAP, JS, and SRW are listed in the appendix . JCC, MC, EI, MK, SCL, RFL, VEO, MEW, SW declare no competing interests related to the submitted work, with full details of other competing interests listed in the appendix . AF, JMG, DG, HVK, JEL, LJS, JL, JM, RM, ETN, KR, WJS, CAS, and FH declare no competing interests.
PY - 2021/4
Y1 - 2021/4
UR - http://www.scopus.com/inward/record.url?scp=85101131601&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101131601&partnerID=8YFLogxK
U2 - 10.1016/S2213-2600(21)00046-1
DO - 10.1016/S2213-2600(21)00046-1
M3 - Comment/debate
C2 - 33539731
AN - SCOPUS:85101131601
SN - 2213-2600
VL - 9
SP - 330
EP - 332
JO - The Lancet Respiratory Medicine
JF - The Lancet Respiratory Medicine
IS - 4
ER -